Literature DB >> 12886815

Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults.

Alison M Elliott1, Patrice A Mawa, Sarah Joseph, Proscovia B Namujju, Moses Kizza, Jessica S Nakiyingi, Christine Watera, David W Dunne, James A Whitworth.   

Abstract

It has been proposed that helminth infection may exacerbate HIV progression by promoting activation of 'type 2' immune responses. To examine this hypothesis, we investigated helminth infection in a cohort of HIV-1-seropositive adults in Entebbe, Uganda, during November 1999 to January 2000. Individuals with helminths were treated. At enroLlment, after 5 weeks and after 4 months, CD4+ and CD8+ T cell counts and viral load were measured. Cytokine responses (interferon [IFN]-gamma, interleukin [IL]-2, IL-4 and IL-5) to Schistosoma mansoni adult worm antigen (SWA), Mycobacterium tuberculosis culture filtrate proteins (CFPs) and phytohaemagglutinin (PHA) were measured in a whole blood assay. At baseline, CD4+ T cell counts and CD4+: CD8+ ratios were higher in individuals with helminths than in those without (median CD4+ T cell counts 467/microL and 268/microL, respectively, P = 0.005). Viral load was lower among those with helminths but this was not statistically significant. During follow-up, CD4+ T cell counts and cytokine responses to PHA fell among individuals without helminths. Among those treated for helminths, CD4+ counts remained stable. Viral loads showed a transient increase at 5 weeks, which was more marked among those treated for helminths, but the levels at 4 months were similar to baseline in both groups. Among those with schistosomiasis, IFN-gamma and IL-2 responses to CFP, and IL-2 and IL-4 responses to PHA declined but there was a sustained increase in cytokine responses to SWA following treatment. These data do not support the hypothesis that helminth infection exacerbates HIV infection. The possibility that chronic helminth infection may suppress HIV replication and that effects on HIV replication may vary during helminth infection and treatment should be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886815     DOI: 10.1016/s0035-9203(03)90040-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  41 in total

Review 1.  Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.

Authors:  Kayvon Modjarrad; Eric Chamot; Sten H Vermund
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

2.  Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline.

Authors:  Paula E Brentlinger; Wilson P Silva; Sten H Vermund; Emilio Valverde; Manuel Buene; Troy D Moon
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-19       Impact factor: 2.205

Review 3.  Species-specific treatment effects of helminth/HIV-1 co-infection: a systematic review and meta-analysis.

Authors:  Laura R Sangaré; Bradley R Herrin; Bradely R Herrin; Grace John-Stewart; Judd L Walson
Journal:  Parasitology       Date:  2011-05-18       Impact factor: 3.234

4.  Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults.

Authors:  Kayvon Modjarrad; Isaac Zulu; David T Redden; Lungowe Njobvu; H Clifford Lane; Zvi Bentwich; Sten H Vermund
Journal:  J Infect Dis       Date:  2005-08-25       Impact factor: 5.226

5.  Association of Schistosomiasis and HIV infection in Tanzania.

Authors:  Jennifer A Downs; Govert J van Dam; John M Changalucha; Paul L A M Corstjens; Robert N Peck; Claudia J de Dood; Heejung Bang; Aura Andreasen; Samuel E Kalluvya; Lisette van Lieshout; Warren D Johnson; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

Review 6.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.

Authors:  Judd L Walson; Phelgona A Otieno; Margaret Mbuchi; Barbra A Richardson; Barbara Lohman-Payne; Steve Wanyee Macharia; Julie Overbaugh; James Berkley; Eduard J Sanders; Michael H Chung; Grace C John-Stewart
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

8.  The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood [ISRCTN32849447].

Authors:  Alison M Elliott; Moses Kizza; Maria A Quigley; Juliet Ndibazza; Margaret Nampijja; Lawrence Muhangi; Linda Morison; Proscovia B Namujju; Moses Muwanga; Narcis Kabatereine; James A G Whitworth
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

9.  Risk factors for helminth, malaria, and HIV infection in pregnancy in Entebbe, Uganda.

Authors:  Patrick William Woodburn; Lawrence Muhangi; Stephen Hillier; Juliet Ndibazza; Proscovia Bazanya Namujju; Moses Kizza; Christine Ameke; Nicolas Emojong Omoding; Mark Booth; Alison Mary Elliott
Journal:  PLoS Negl Trop Dis       Date:  2009-06-30

10.  Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection.

Authors:  Mila Ayash-Rashkovsky; Agnès-Laurence Chenine; Lisa N Steele; Sandra J Lee; Ruijiang Song; Helena Ong; Robert A Rasmussen; Regina Hofmann-Lehmann; James G Else; Peter Augostini; Harold M McClure; W Evan Secor; Ruth M Ruprecht
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.